TipRanks
Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2
UK Market
0LB2
Supernus Pharmaceuticals
RESEARCH TOOLSreports

Supernus Pharmaceuticals (0LB2) Balance Sheet

0 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q3 2026 were $1.40B, a decrease of -2.13% from the previous quarter. GB:0LB2 total liabilities were $335.21M for the fiscal quarter, a -15.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.45B$ 1.37B$ 1.28B$ 1.70B$ 1.69B
Total Liabilities
$ 390.93M$ 332.34M$ 356.16M$ 816.30M$ 873.30M
Total Equity Gross Minority
$ 1.06B$ 1.04B$ 921.52M$ 886.20M$ 815.85M
Other Metrics
Currency in USD

Supernus Pharmaceuticals Debt to Assets